The companies collaborate to advance the discovery of novel biomarkers & drug targets using spatial imaging & ML technologies
The collaboration combines NanoString’s GeoMx DSP spatial biology platforms with Visiopharm’s AI-driven image analysis capabilities to enable integrated workflows for translational research studies. NanoString’s AtoMx Spatial Informatics Platform will improve integration by delivering scalable computing power with global access
The technologies will advance biomarker development & validation through in situ whole transcriptome & high-plex protein analysis. By incorporating Visiopharm’s Oncotopix Discovery software into GeoMx DSP workflow, sample processing for translational research applications will enhance & simplified
Ref: Businesswire | Image: NanoString
